Proposed Data Collections Submitted for Public Comment and Recommendations, 54747-54748 [05-18407]
Download as PDF
<![CDATA[
Federal Register / Vol. 70, No. 179 / Friday, September 16, 2005 / Notices
A. Federal Reserve Bank of New
York (Jay Bernstein, Bank Supervision
Officer) 33 Liberty Street, New York,
New York 10045-0001:
1. Commonwealth Bank of Australia,
Sydney, Australia; to acquire approval
pursuant to Section 4(c)(8) of the BHC
Act and Section 225.24(a) of Regulation
Y, for its wholly-owned subsidiary,
CommSec LLC, New York, New York, to
engage in securities brokerage, private
placement services, futures commission
merchant, and other transactional
services pursuant to Section
225.28(b)(7)(i)of Regulation Y.
Board of Governors of the Federal Reserve
System, September 13, 2005.
Robert deV. Frierson,
Deputy Secretary of the Board.
[FR Doc.05–18466 Filed 9–15–05; 8:45 am]
BILLING CODE 6210–01–S
FEDERAL RESERVE SYSTEM
Formations of, Acquisitions by, and
Mergers of Bank Holding Companies
The companies listed in this notice
have applied to the Board for approval,
pursuant to the Bank Holding Company
Act of 1956 (12 U.S.C. 1841 et seq.)
(BHC Act), Regulation Y (12 CFR Part
225), and all other applicable statutes
and regulations to become a bank
holding company and/or to acquire the
assets or the ownership of, control of, or
the power to vote shares of a bank or
bank holding company and all of the
banks and nonbanking companies
owned by the bank holding company,
including the companies listed below.
The applications listed below, as well
as other related filings required by the
Board, are available for immediate
inspection at the Federal Reserve Bank
indicated. The application also will be
available for inspection at the offices of
the Board of Governors. Interested
persons may express their views in
writing on the standards enumerated in
the BHC Act (12 U.S.C. 1842(c)). If the
proposal also involves the acquisition of
a nonbanking company, the review also
includes whether the acquisition of the
nonbanking company complies with the
standards in section 4 of the BHC Act
(12 U.S.C. 1843). Unless otherwise
noted, nonbanking activities will be
conducted throughout the United States.
Additional information on all bank
holding companies may be obtained
from the National Information Center
website at www.ffiec.gov/nic/.
Unless otherwise noted, comments
regarding each of these applications
must be received at the Reserve Bank
indicated or the offices of the Board of
VerDate Aug<31>2005
15:04 Sep 15, 2005
Jkt 205001
Governors not later than October 11,
2005.
A. Federal Reserve Bank of Atlanta
(Andre Anderson, Vice President) 1000
Peachtree Street, N.E., Atlanta, Georgia
30303:
1. Synovus Financial Corp.,
Columbus, Georgia; to merge with
Riverside Bancshares, Inc., Marietta,
Georgia, and thereby indirectly acquire
Riverside Bank, Marietta, Georgia.
B. Federal Reserve Bank of
Minneapolis (Jacqueline G. King,
Community Affairs Officer) 90
Hennepin Avenue, Minneapolis,
Minnesota 55480-0291:
1. Abdo Investments, Inc., Edina,
Minnesota; to become a bank holding
company by acquiring 24.2 percent of
the voting shares of Rivers Ridge
Holding Company, Edina, Minnesota,
and thereby indirectly acquire
Bankvista, Sartell, Minnesota.
Board of Governors of the Federal Reserve
System, September 12, 2005.
Robert deV. Frierson,
Deputy Secretary of the Board.
[FR Doc. 05–18383 Filed 9–15–05; 8:45 am]
BILLING CODE 6210–01–S
GENERAL SERVICES
ADMINISTRATION
Office of Governmentwide
Policy, General Services Administration
(GSA).
ACTION: Notice of a deviation.
AGENCY:
SUMMARY: This notice announces that
the General Services Administration
(GSA), Office of Governmentwide Policy
(M), is granting a deviation from section
102–34.335 of the Federal Management
Regulation (FMR) (41 CFR 102–34.335)
to all agencies whose purchase of
gasoline for motor vehicles has been
impacted by Hurricane Katrina. This
deviation will allow Federal agencies to
purchase premium gasoline for
government owned and leased vehicles
when lower grade gasoline is not
available. This deviation can be found at
www.gsa.gov/vehiclepolicy and clicking
on ‘‘Deviation from 41 CFR 102–
34.335’’.
The deviation announced in this
notice is effective September 8, 2005.
FOR FURTHER INFORMATION CONTACT: For
clarification of content, contact General
Services Administration, Office of
Governmentwide Policy, Office of
Travel, Transportation and Asset
Management, at (202) 501–1777 and cite
PO 00000
Frm 00044
Fmt 4703
Sfmt 4703
the deviation regarding motor vehicle
management dated September 8, 2005.
SUPPLEMENTARY INFORMATION:
A. Background
Federal Management Regulation
(FMR) section 102–34.335 (41 CFR 102–
34.335) prohibits the use of premium
grade gasoline in any motor vehicle
owned or leased by the Government
unless the motor vehicle specifically
requires premium grade gasoline. This
section states that drivers are to use the
grade (octane rating) of gasoline
recommended by the motor vehicle
manufacturer when fueling motor
vehicles owned or leased by the
Government.
As a result of the catastrophic
destruction caused by Hurricane
Katrina, agencies have reported that
their vehicles operators are unable to
purchase lower octane gasoline for their
vehicles to complete their missions. In
many areas, agencies have only been
able to procure premium gasoline for
use in their motor vehicles. The original
intent of section 102–34.335 was to
reduce fuel costs and eliminate the
unnecessary use of premium gasoline in
vehicles capable of being operated on
lower grade gasoline.
B. Procedures
Notice of a Deviation; Motor Vehicle
Management
DATES:
54747
This deviation is located on the
Internet at www.gsa.gov/vehiclepolicy
and clicking on ‘‘Deviation from 41 CFR
102–34.335’’.
Dated: September 12, 2005.
Tom Horan,
Deputy Director.
[FR Doc. 05–18408 Filed 9–15–05; 8:45 am]
BILLING CODE 6820–14–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–05–0494]
Proposed Data Collections Submitted
for Public Comment and
Recommendations
The Centers for Disease Control and
Prevention (CDC) publishes a list of
information collection requests under
review by the Office of Management and
Budget (OMB) in compliance with the
Paperwork Reduction Act (44 U.S.C.
Chapter 35). To request a copy of these
requests, call the CDC Reports Clearance
Officer at (404) 371–5983 or send an
email to omb@cdc.gov. Send written
comments to CDC Desk Officer, Office of
Management and Budget, Washington,
E:\FR\FM\16SEN1.SGM
16SEN1
54748
Federal Register / Vol. 70, No. 179 / Friday, September 16, 2005 / Notices
DC or by fax to (202) 395–6974. Written
comments should be received within 30
days of this notice.
Proposed Project
Exposure to Aerosolized Brevetoxins
during Red Tide Events (OMB No.
0920–0494)—Revision—National Center
for Environmental Health (NCEH),
Centers for Disease Control and
Prevention (CDC).
Karenia brevis (formerly
Gymnodinium breve) is the marine
dinoflagellate responsible for extensive
blooms (called red tides) that form in
the Gulf of Mexico. K. brevis produces
potent toxins, called brevetoxins, which
have been responsible for killing
millions of fish and other marine
organisms. The biochemical activity of
brevetoxins is not completely
understood and there is very little
information regarding human health
effects from environmental exposures,
such as inhaling brevetoxin that has
been aerosolized and swept onto the
coast by offshore winds. The National
the same symptom questionnaires and
spirometry tests) during a more severe
red tide event.
In addition, we are now planning to
quantify the levels of cytokines in nasal
exudates to assess whether they can be
used to verify exposure and to
demonstrate a biological effect (i.e.,
allergic response) following inhalation
of aerosolized brevetoxins. We plan to
include not only the study subjects who
have been involved in our earlier
studies, but also any new individuals
who are hired to work at the relevant
beaches. As mentioned above, we have
collected part data on occupational
exposure to red tides. However, because
we are dealing with natural phenomena
and are subject literally to the tides, and
because the scientific questions are
evolving as we learn more, we must
extend our data collection time for an
additional three years. There are no
costs to respondents except for their
time. The total estimated total burden
hours are 195.
Center for Environmental Health
(NCEH), Centers for Disease Control and
Prevention (CDC) has recruited people
who work along the coast of Florida and
who are periodically occupationally
exposed to aerosolized red tide toxins.
We have administered a baseline
respiratory health questionnaire and
conducted pre- and post-shift
pulmonary function tests during a time
when there is no red tide reported near
the area. When a red tide developed, we
administered a symptom survey and
conducted pulmonary function testing
(PFT). We compared (1) symptom
reports before and during the red tide
and (2) the changes in baseline PFT
values during the work shift (differences
between pre- and post-shift PFT results)
without exposure to red tide with the
changes in PFT values during the work
shift when individuals are exposed to
red tide.
The exposures experienced by our
study cohort have been minimal, and
we plan to conduct another study (using
ESTIMATE OF ANNUALIZED BURDEN TABLE
Number of respondents
Respondents
Number of responses per
respondent
5
25
25
25
25
5
1
6
6
6
6
160
Pulmonary History Questionnaire ................................................................................................
Spirometry ....................................................................................................................................
Nasal exudates collection/Nasal wash ........................................................................................
Symptom Questionnaire ..............................................................................................................
Hearing test .................................................................................................................................
Beach Survey ..............................................................................................................................
Dated: September 9, 2005.
Joan Karr,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. 05–18407 Filed 9–15–05; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Mind/Body
Research and Chronic Disease
Conditions, Request for Applications
Number DP–05–133
Correction: This notice was published
in the Federal Register on September 8,
2005, Volume 70, Number 173, pages
53375–53376. The time and date of the
meeting has been changed.
Time and Date: 2 p.m.–3:30 p.m.,
September 22, 2005.
Meeting Location: Teleconference.
VerDate Aug<31>2005
15:04 Sep 15, 2005
Jkt 205001
Contact Person for More Information:
J. Felix Rogers, PhD, Scientific Review
Administrator, National Center for
Chronic Disease Prevention and Health
Promotion, 4770 Buford Highway, MS–
K92, Atlanta, GA 30341, Telephone
404.639.6101.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both CDC
and the Agency for Toxic Substances
and Disease Registry.
Dated: September 9, 2005.
Alvin Hall,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 05–18404 Filed 9–15–05; 8:45 am]
BILLING CODE 4163–18–P
PO 00000
Frm 00045
Fmt 4703
Sfmt 4703
Average burden per response
20/60
20/60
10/60
5/60
15/60
5/60
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[Document Identifier: CMS–10036]
Agency Information Collection
Activities: Proposed Collection;
Comment Request
Centers for Medicare &
Medicaid Services, HHS.
In compliance with the requirement
of section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995, the
Centers for Medicare & Medicaid
Services (CMS) is publishing the
following summary of proposed
collections for public comment.
Interested persons are invited to send
comments regarding this burden
estimate or any other aspect of this
collection of information, including any
of the following subjects: (1) The
necessity and utility of the proposed
information collection for the proper
performance of the agency’s functions;
AGENCY:
E:\FR\FM\16SEN1.SGM
16SEN1
]]>Agencies
[Federal Register Volume 70, Number 179 (Friday, September 16, 2005)]
[Notices]
[Pages 54747-54748]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-18407]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-05-0494]
Proposed Data Collections Submitted for Public Comment and
Recommendations
The Centers for Disease Control and Prevention (CDC) publishes a
list of information collection requests under review by the Office of
Management and Budget (OMB) in compliance with the Paperwork Reduction
Act (44 U.S.C. Chapter 35). To request a copy of these requests, call
the CDC Reports Clearance Officer at (404) 371-5983 or send an email to
omb@cdc.gov. Send written comments to CDC Desk Officer, Office of
Management and Budget, Washington,
[[Page 54748]]
DC or by fax to (202) 395-6974. Written comments should be received
within 30 days of this notice.
Proposed Project
Exposure to Aerosolized Brevetoxins during Red Tide Events (OMB No.
0920-0494)--Revision--National Center for Environmental Health (NCEH),
Centers for Disease Control and Prevention (CDC).
Karenia brevis (formerly Gymnodinium breve) is the marine
dinoflagellate responsible for extensive blooms (called red tides) that
form in the Gulf of Mexico. K. brevis produces potent toxins, called
brevetoxins, which have been responsible for killing millions of fish
and other marine organisms. The biochemical activity of brevetoxins is
not completely understood and there is very little information
regarding human health effects from environmental exposures, such as
inhaling brevetoxin that has been aerosolized and swept onto the coast
by offshore winds. The National Center for Environmental Health (NCEH),
Centers for Disease Control and Prevention (CDC) has recruited people
who work along the coast of Florida and who are periodically
occupationally exposed to aerosolized red tide toxins.
We have administered a baseline respiratory health questionnaire
and conducted pre- and post-shift pulmonary function tests during a
time when there is no red tide reported near the area. When a red tide
developed, we administered a symptom survey and conducted pulmonary
function testing (PFT). We compared (1) symptom reports before and
during the red tide and (2) the changes in baseline PFT values during
the work shift (differences between pre- and post-shift PFT results)
without exposure to red tide with the changes in PFT values during the
work shift when individuals are exposed to red tide.
The exposures experienced by our study cohort have been minimal,
and we plan to conduct another study (using the same symptom
questionnaires and spirometry tests) during a more severe red tide
event.
In addition, we are now planning to quantify the levels of
cytokines in nasal exudates to assess whether they can be used to
verify exposure and to demonstrate a biological effect (i.e., allergic
response) following inhalation of aerosolized brevetoxins. We plan to
include not only the study subjects who have been involved in our
earlier studies, but also any new individuals who are hired to work at
the relevant beaches. As mentioned above, we have collected part data
on occupational exposure to red tides. However, because we are dealing
with natural phenomena and are subject literally to the tides, and
because the scientific questions are evolving as we learn more, we must
extend our data collection time for an additional three years. There
are no costs to respondents except for their time. The total estimated
total burden hours are 195.
Estimate of Annualized Burden Table
----------------------------------------------------------------------------------------------------------------
Number of
Respondents Number of responses per Average burden
respondents respondent per response
----------------------------------------------------------------------------------------------------------------
Pulmonary History Questionnaire................................. 5 1 20/60
Spirometry...................................................... 25 6 20/60
Nasal exudates collection/Nasal wash............................ 25 6 10/60
Symptom Questionnaire........................................... 25 6 5/60
Hearing test.................................................... 25 6 15/60
Beach Survey.................................................... 5 160 5/60
----------------------------------------------------------------------------------------------------------------
Dated: September 9, 2005.
Joan Karr,
Acting Reports Clearance Officer, Centers for Disease Control and
Prevention.
[FR Doc. 05-18407 Filed 9-15-05; 8:45 am]
BILLING CODE 4163-18-P
